Zealand’s GLP-2 candidate shows early weight loss results
Zealand Pharma said that its obesity candidate that uses a unique mechanism led to notable weight loss in an early trial.
Related Articles
PEPFAR keeps millions of people with HIV alive and may be spared from Trump spending cuts
The HIV/AIDS program known as PEPFAR has faced a severe threat as the Trump administration dismantles most foreign aid, but on Tuesday it appeared to be spared…
An unusual use for AI in medical education
In this edition of AI Prognosis: A look at AI in medical education, CASP getting caught up in NIH chaos, and trust in AI.
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism.
Kennedy dismisses two top HHS aides
HHS hasn’t said why two top aides to RFK Jr. were dismissed this week.
Tech news: 14 Channels of Data with Compact Wearable
Explore the specifications of the Fibion Vitals, a cutting-edge wearable device designed for comprehensive health monitoring. This episode provides a detaile…
Fibion Sleep Advanced Actigraphy for Sleep & Activity Research – Fibion
Uncover advanced sleep and activity insights with Fibion Sleep. Offering 24-hour data collection, long-lasting battery, and flexible algorithmic analysis for comprehensive research
25 years ago, I reported on horrifying hospital errors. Here’s what’s changed since then — and what hasn’t
Twenty-five years ago, Larry Tye reported on hospital errors for the Boston Globe. His recent wrist surgery showed just how much things have changed since…
Scientists show that mRNA therapy can be delivered as a capsule
Researchers used a capsule engineered to prevent stomach acids from degrading liquid mRNA therapy to treat inflammatory bowel disease.
Births of eight healthy children show promise of mitochondrial replacement therapy
A pioneering reproductive technology reduced the risk of children inheriting disease-causing mutations in mitochondria, researchers reported.
AI Risk Calculator Outperforms EAU Models for Bladder Cancer Prognosis – Alexandre Zlotta
Ashish Kamat is joined by Alexandre Zlotta to discuss the evolution of AI in bladder cancer management. Dr. Zlotta highlights work developing an AI model…
